Switch Therapeutics
San Francisco, USA
|
Switch Therapeutics is a biotechnology company pioneering a new type of medicine that integrates nucleic acid nanotechnology and RNA interference (RNAi) science, to treat a range of diseases - affecting the central nervous system and systemic indications – with significant unmet need. The CASi (Conditionally Activated siRNA) platform, the company’s gene knockdown approach, is based on technology developed by renowned researchers in the field of RNA and drug development. CASi combines advantageous...